{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T04:31:01Z","timestamp":1786336261574,"version":"build-2736575974"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Evidence regarding whether dietary interventions can delay disease progression in men undergoing active surveillance for prostate cancer remains fragmented. This study innovatively combines a systematic review of the evidence with rigorous methodological assessment, aiming to provide a critical analysis of the evidence base in this field, rather than merely a descriptive review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched the PubMed, Embase, Cochrane Library, and Web of Science databases, mapping interventions to outcomes. An evidence bubble plot was constructed, with the bubble size representing the number of studies and the color intensity representing the proportion of randomized controlled trials. Methodological quality were assessed using the Cochrane risk of bias tool, ROBINS-I, the Newcastle\u2013Ottawa Scale and the JBI tool.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The map revealed a dense but flawed evidence cluster focused on phytochemical-rich supplements and PSA\/biomarker change, primarily supported by randomized controlled trials with prevalent limitations in blinding and randomization reporting. In stark contrast, there is a critical gap in the evidence from intervention studies assessing the impact of holistic dietary patterns on clinical progression endpoints. The integrated quality assessment underscores a fundamental mismatch: while abundant, research on supplements is often methodologically compromised, conversely, the few observational studies on holistic dietary patterns, although of higher quality, are unable to establish causality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Current evidence is misaligned with clinical needs, being rich in low-certainty supplement data but scarce in high-quality trials on holistic diets. Future research would benefit greatly from a strategic reorientation of funding\u2014namely, prioritizing large-scale, rigorous clinical trials to evaluate comprehensive dietary interventions targeting clinically significant disease progression endpoints, while recognizing that supplement studies continue to play an important role in generating mechanistic hypotheses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/doi.org\/10.17605\/OSF.IO\/T8G97<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2026.1911038","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T04:22:36Z","timestamp":1786335756000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond supplements and surrogates: an evidence-quality map informs a strategic rebalancing of dietary research in prostate cancer active surveillance"],"prefix":"10.3389","volume":"13","author":[{"given":"Ying","family":"Li","sequence":"first","affiliation":[{"name":"Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan","place":["Shandong, China"]},{"name":"Department of Urology, Shandong Provincial Hospital, Jinan","place":["Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Qi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan","place":["Shandong, China"]},{"name":"Department of Urology, Shandong Provincial Hospital, Jinan","place":["Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Yun","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan","place":["Shandong, China"]},{"name":"Department of Urology, Shandong Provincial Hospital, Jinan","place":["Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Ping","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Nursing, Health Science Center, Xi\u2019an Jiaotong University, Xi\u2019an","place":["Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan","place":["Shandong, China"]},{"name":"Department of Urology, Shandong Provincial Hospital, Jinan","place":["Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","article-title":"2022 update on prostate cancer epidemiology and risk factors-a systematic review.","volume":"84","author":"Bergengren","year":"2023","journal-title":"Eur Urol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/bju.70005","article-title":"Interventions for patients with prostate cancer on active surveillance: a narrative review.","volume":"136","author":"Gill","year":"2025","journal-title":"BJU Int."},{"key":"B3","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.euo.2024.07.003","article-title":"Has active surveillance for prostate cancer become safer? lessons learned from a global clinical registry.","volume":"8","author":"Bangma","year":"2025","journal-title":"Eur Urol Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.eururo.2015.01.004","article-title":"Systematic review and meta-analysis of factors determining change to radical treatment in active surveillance for localized prostate cancer.","volume":"67","author":"Simpkin","year":"2015","journal-title":"Eur Urol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.eururo.2023.02.009","article-title":"A comprehensive 6-mo prostate cancer patient empowerment program decreases psychological distress among men undergoing curative prostate cancer treatment: a randomized clinical trial.","volume":"83","author":"Ilie","year":"2023","journal-title":"Eur Urol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1001\/jamaoncol.2024.4406","article-title":"Diet quality, dietary inflammatory potential, and risk of prostate cancer grade reclassification.","volume":"10","author":"Su","year":"2024","journal-title":"JAMA Oncol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1080\/01635581.2022.2143537","article-title":"Dietary patterns and risk of gleason grade progression among men on active surveillance for prostate cancer: results from the canary prostate active surveillance study.","volume":"75","author":"Schenk","year":"2023","journal-title":"Nutr Cancer."},{"key":"B8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1017\/rsm.2024.9","article-title":"Key concepts and reporting recommendations for mapping reviews: a scoping review of 68 guidance and methodological studies.","volume":"16","author":"Li","year":"2025","journal-title":"Res Synth Methods."},{"key":"B9","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41416-019-0380-2","article-title":"Diet quality and Gleason grade progression among localised prostate cancer patients on active surveillance.","volume":"120","author":"Gregg","year":"2019","journal-title":"Br J Cancer."},{"key":"B10","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1200\/jco.24.00608","article-title":"High Omega-3, low Omega-6 diet with fish oil for men with prostate cancer on active surveillance: the CAPFISH-3 randomized clinical trial.","volume":"43","author":"Aronson","year":"2025","journal-title":"J Clin Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1158\/1940-6207.Capr-13-0349","article-title":"Prostatic and dietary omega-3 fatty acids and prostate cancer progression during active surveillance.","volume":"7","author":"Moreel","year":"2014","journal-title":"Cancer Prev Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.3390\/nu11071616","article-title":"Omega-3 fatty acids survey in men under active surveillance for prostate cancer: from intake to prostate tissue level.","volume":"11","author":"Moussa","year":"2019","journal-title":"Nutrients."},{"key":"B13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10552-010-9684-5","article-title":"Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer.","volume":"22","author":"Chan","year":"2011","journal-title":"Cancer Causes Control."},{"key":"B14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/pros.24076","article-title":"A phase II randomized placebo-controlled trial of pomegranate fruit extract in men with localized prostate cancer undergoing active surveillance.","volume":"81","author":"Jarrard","year":"2021","journal-title":"Prostate."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1093\/ajcn\/nqz012","article-title":"Transcriptional changes in prostate of men on active surveillance after a 12-mo glucoraphanin-rich broccoli intervention-results from the Effect of Sulforaphane on prostate CAncer PrEvention (ESCAPE) randomized controlled trial.","volume":"109","author":"Traka","year":"2019","journal-title":"Am J Clin Nutr."},{"key":"B16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.euo.2025.10.003","article-title":"Increasing phytochemical-rich foods and lactobacillus probiotics in men with low-risk prostate cancer-a randomised, double-blind, placebo-controlled trial.","volume":"9","author":"Thomas","year":"2026","journal-title":"Eur Urol Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/pcan.2014.6","article-title":"A double-blind, placebo-controlled randomised trial evaluating the effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer\u2013the U.K. NCRN Pomi-T study.","volume":"17","author":"Thomas","year":"2014","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.3390\/cancers16213634","article-title":"Nutritional supplement with fermented soy in patients under active surveillance for low-risk or intermediate-risk prostate cancer: results from the praemune trial.","volume":"16","author":"Van der Eecken","year":"2024","journal-title":"Cancers."},{"key":"B19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.urology.2003.09.061","article-title":"Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer.","volume":"63","author":"deVere White","year":"2004","journal-title":"Urology."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1080\/01635581.2010.492085","article-title":"Effects of a high dose, aglycone-rich soy extract on prostate-specific antigen and serum isoflavone concentrations in men with localized prostate cancer.","volume":"62","author":"deVere White","year":"2010","journal-title":"Nutr Cancer."},{"key":"B21","doi-asserted-by":"publisher","first-page":"8165686","DOI":"10.1155\/proc\/8165686","article-title":"Preliminary evidence on safety and clinical efficacy of luteolin for patients with prostate cancer under active surveillance.","volume":"2025","author":"Naiki","year":"2025","journal-title":"Prostate Cancer."},{"key":"B22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jsbmb.2012.11.012","article-title":"Vitamin D3 supplementation, low-risk prostate cancer, and health disparities.","volume":"136","author":"Hollis","year":"2013","journal-title":"J Steroid Biochem Mol Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1210\/jc.2012-1451","article-title":"Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance.","volume":"97","author":"Marshall","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"B24","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41416-025-03278-w","article-title":"High-dose vitamin D supplementation and prostate cancer progression: a phase II randomised trial in localised prostate cancer cases with intermediate risk of progression (ProsD).","volume":"134","author":"Nair-Shalliker","year":"2026","journal-title":"Br J Cancer."},{"key":"B25","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.clnesp.2021.06.004","article-title":"Feasibility of dietary folic acid reduction intervention for men on active surveillance for prostate cancer.","volume":"44","author":"Ullevig","year":"2021","journal-title":"Clin Nutr ESPEN."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1158\/1940-6207.Capr-09-0143","article-title":"Oral selenium supplementation has no effect on prostate-specific antigen velocity in men undergoing active surveillance for localized prostate cancer.","volume":"3","author":"Stratton","year":"2010","journal-title":"Cancer Prev Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1111\/j.1464-410X.2007.07365.x","article-title":"Dietary modification in patients with prostate cancer on active surveillance: a randomized, multicentre feasibility study.","volume":"101","author":"Parsons","year":"2008","journal-title":"BJU Int."},{"key":"B28","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1001\/jama.2019.20207","article-title":"Effect of a behavioral intervention to increase vegetable consumption on cancer progression among men with early-stage prostate cancer: the meal randomized clinical trial.","volume":"323","author":"Parsons","year":"2020","journal-title":"JAMA."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1002\/pros.22682","article-title":"A study of caloric restriction versus standard diet in overweight men with newly diagnosed prostate cancer: a randomized controlled trial.","volume":"73","author":"Wright","year":"2013","journal-title":"Prostate."},{"key":"B30","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials.","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ."},{"key":"B31","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/jre.13405","article-title":"Risk of bias evaluation of cross-sectional studies: adaptation of the newcastle-ottawa scale.","author":"Carra","year":"2025","journal-title":"J Periodontal Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"378","DOI":"10.11124\/jbies-23-00268","article-title":"The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies.","volume":"22","author":"Barker","year":"2024","journal-title":"JBI Evid Synth."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/jnci\/djae051","article-title":"Dietary interventions in cancer: a systematic review of all randomized controlled trials.","volume":"116","author":"Ilerhunmwuwa","year":"2024","journal-title":"J Natl Cancer Inst."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1371\/journal.pmed.0040005","article-title":"Relationship between funding source and conclusion among nutrition-related scientific articles.","volume":"4","author":"Lesser","year":"2007","journal-title":"PLoS Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.eururo.2025.07.017","article-title":"Dietary patterns in prostate cancer prevention and management: a systematic review of prospective cohort studies and randomized clinical trials.","volume":"88","author":"Lin","year":"2025","journal-title":"Eur Urol."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000005116","article-title":"Diet, exercise, and risk of prostate cancer progression: current evidence in active surveillance.","author":"Campbell","year":"2026","journal-title":"J Urol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.3390\/jcm15093369","article-title":"Lifestyle interventions in patients in active surveillance for prostate cancer: a systematic review.","volume":"28","author":"Campetella","year":"2026","journal-title":"J Clin Med."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1911038\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T04:22:37Z","timestamp":1786335757000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1911038\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":38,"alternative-id":["10.3389\/fnut.2026.1911038"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1911038","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"article-number":"1911038"}}